News
BIOCORP und SANOFI erweitern ihre Partnerschaft mit Mallya Smart Sensors
Pflichtmitteilung:
BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA PME), ein französisches Unternehmen, das sich auf die Entwicklung und Herstellung von medizinischen Geräten und
Median Technologies Announces Preliminary 2019 Unaudited Financial Results
Regulatory News:
Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® today announced its preliminary full year 2019 unaudited financial results. These results fully validate the
Sensorion Announces its Presence in San Francisco during the 38th annual J.P. Morgan Healthcare Conference
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the
Mauna Kea Technologies Announces Publication of Positive Results on Needle-Based Endomicroscopy for the Clinical Management of Pancreatic Cystic Lesions
Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today
Sensorion Announces Positive Data Safety Monitoring Board Review of Phase 2 Trial for SENS-401 in Sudden Sensorineural Hearing Loss
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent
Sensorion Announces €5.6m Non-Dilutive Funding to Support SENS-401 Phase 2 Study in Sudden Sensorineural Hearing Loss; French Ministry of Armed Forces to Participate in the Study
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN / PEA-PME eligible) a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore
EOS imaging Announces Its Financial Agenda For 2020
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
Mauna Kea Technologies Announces Strategic Equity Investment of €7.5 Million by Johnson & Johnson Innovation
Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE)
GROUPE LDLC : MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 SEPTEMBRE 2019
LDLC.com annonce avoir mis à la disposition du public et déposé auprès d'Euronext son rapport financier semestriel au 30 septembre 2019.
Ce document est disponible sur le site de la société à
BIOCORP und SANOFI kooperieren bei der weltweiten Ausstattung des Insulinpens SoloStar mit Mallya-Technologie
BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), ein französisches Unternehmen mit Spezialisierung in der Entwicklung und Herstellung von Medizinprodukten und intelligenten Systemen
BIOCORP and SANOFI Announce a Partnership to Fit SoloStar Insulin Pens With Mallya Technology Worldwide
Regulatory News:
BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), a French company specializing in the development and manufacturing of medical devices and smart drug delivery
GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191210006078/en/
Figure 1. LHON Natural History from Interim Analysis
The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191208005050/en/
The National Eye Hospital (CHNO) of the Quinze-Vingt
Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN / PEA-PME eligible), a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore
EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191128005574/en/
EOSedge™ (Photo: Business Wire)
EOS imaging
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005639/en/
(Photo: Business Wire)
EOS imaging (Paris:EOSI)
EOS imaging Announces 350th System Worldwide Installed at University of Missouri Health Care
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
EOS imaging to Present Advanced Orthopedic Solutions at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2019
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
Sensorion Announces an Oral Presentation of New SENS-401 Preclinical Data at ISIET 2019 in Hannover
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specializes in the development of novel therapies to restore, treat and
Wirecard: Neue Kooperation mit ALDI sorgt für kräftiges Kursplus
EON MOTORS GROUP - RESULTAT OFFRE VOLONTAIRE DE RACHAT DES ACTIONS EON MOTORS GROUP
CIBOX : Autorisation de la signature des accords de partenariat et de rapprochement entre CXM et CIBOX - Report au 15 avril 2018 de la date butoir pour la signature des accords
WEACCESS GROUP (ex INFOSAT TELECOM) : WEACCESS GROUP ELIGIBLE AU DISPOSITIF PEA-PME
Fermentalg enters US natural specialty ingredients market
MND lance une augmentation de capital de 26,4 M EUR avec maintien du DPS des actionnaires afin de concrétiser ses ambitions à horizon 2020